China Pharma Holdings (CPHI) Other Accumulated Expenses (2019 - 2023)
China Pharma Holdings' (CPHI) quarterly Other Accumulated Expenses came in at $1.1 million in Q4 2023, down 54.21% YoY from $2.5 million in Q4 2022, and up 2.2% on a QoQ basis from $1.1 million in Q3 2023.
China Pharma Holdings (CPHI) Other Accumulated Expenses (2019 - 2023) Analysis & Trends
China Pharma Holdings (CPHI) has 5 years of Other Accumulated Expenses data on file, last reported at $1.1 million in Q4 2023.
- Quarterly Other Accumulated Expenses fell 54.21% year-over-year to $1.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (down 54.21% YoY) and the FY2023 annual result came in at $1.1 million, down 54.21% from the prior year.
- Other Accumulated Expenses rose to $1.1 million in Q4 2023, from $1.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $3.1 million in Q3 2021 to a low of $1.1 million in Q3 2023.
- A 5-year average of $2.3 million and a median of $2.5 million in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 30.23% — and 2023, when it slumped 54.69%.
- Tracing CPHI's Other Accumulated Expenses over 5 years: stood at $2.1 million in 2019, then gained by 3.01% to $2.1 million in 2020, then soared by 30.23% to $2.8 million in 2021, then fell by 10.93% to $2.5 million in 2022, then slumped by 54.21% to $1.1 million in 2023.
- The last three Other Accumulated Expenses figures came in at $1.1 million (Q4 2023), $1.1 million (Q3 2023), and $2.5 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | 2.78 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Jun 30, 2021 | 2.82 Mn |
| Mar 31, 2021 | 2.18 Mn |
| Dec 31, 2020 | 2.13 Mn |
| Dec 31, 2019 | 2.07 Mn |